Baseline phenotypes with preserved β-cell function and high insulin concentrations have the best improvements in glucose tolerance after weight loss: results from the prospective DEXLIFE and EGIR-RISC studies

S. Sabatini; J.J. Nolan; G. O'Donoghue; A. Kennedy; J. Petrie; M. Walker; D.J. O'Gorman; A. Gastaldelli

doi:10.1016/j.metabol.2024.155910

Baseline phenotypes with preserved β-cell function and high insulin concentrations have the best improvements in glucose tolerance after weight loss: results from the prospective DEXLIFE and EGIR-RISC studies

S. Sabatini
, J.J. Nolan
, G. O'Donoghue
, A. Kennedy
, J. Petrie
, M. Walker
, D.J. O'Gorman
, A. Gastaldelli

Research output: Contribution to journal › Article › peer-review

Original language	Undefined/Unknown
Journal	Metabolism: Clinical and Experimental
DOIs	https://doi.org/10.1016/j.metabol.2024.155910
Publication status	Published - 2024

Access to Document

10.1016/j.metabol.2024.155910

Cite this

Sabatini, S., Nolan, J. J., O'Donoghue, G., Kennedy, A., Petrie, J., Walker, M., O'Gorman, D. J., & Gastaldelli, A. (2024). Baseline phenotypes with preserved β-cell function and high insulin concentrations have the best improvements in glucose tolerance after weight loss: results from the prospective DEXLIFE and EGIR-RISC studies. Metabolism: Clinical and Experimental. https://doi.org/10.1016/j.metabol.2024.155910

@article{e277496b272044f9a1266fec414b4b0a,

title = "Baseline phenotypes with preserved β-cell function and high insulin concentrations have the best improvements in glucose tolerance after weight loss: results from the prospective DEXLIFE and EGIR-RISC studies",

author = "S. Sabatini and J.J. Nolan and G. O'Donoghue and A. Kennedy and J. Petrie and M. Walker and D.J. O'Gorman and A. Gastaldelli",

year = "2024",

doi = "10.1016/j.metabol.2024.155910",

language = "Undefined/Unknown",

journal = "Metabolism: Clinical and Experimental",

issn = "0026-0495",

publisher = "W.B. Saunders",

}

Sabatini, S, Nolan, JJ, O'Donoghue, G, Kennedy, A, Petrie, J, Walker, M, O'Gorman, DJ & Gastaldelli, A 2024, 'Baseline phenotypes with preserved β-cell function and high insulin concentrations have the best improvements in glucose tolerance after weight loss: results from the prospective DEXLIFE and EGIR-RISC studies', Metabolism: Clinical and Experimental. https://doi.org/10.1016/j.metabol.2024.155910

Baseline phenotypes with preserved β-cell function and high insulin concentrations have the best improvements in glucose tolerance after weight loss: results from the prospective DEXLIFE and EGIR-RISC studies. / Sabatini, S.; Nolan, J.J.; O'Donoghue, G. et al.
In: Metabolism: Clinical and Experimental, 2024.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Baseline phenotypes with preserved β-cell function and high insulin concentrations have the best improvements in glucose tolerance after weight loss: results from the prospective DEXLIFE and EGIR-RISC studies

AU - Sabatini, S.

AU - Nolan, J.J.

AU - O'Donoghue, G.

AU - Kennedy, A.

AU - Petrie, J.

AU - Walker, M.

AU - O'Gorman, D.J.

AU - Gastaldelli, A.

PY - 2024

Y1 - 2024

UR - http://www.scopus.com/inward/record.url?eid=2-s2.0-85191777340&partnerID=MN8TOARS

U2 - 10.1016/j.metabol.2024.155910

DO - 10.1016/j.metabol.2024.155910

M3 - Article

SN - 0026-0495

JO - Metabolism: Clinical and Experimental

JF - Metabolism: Clinical and Experimental

ER -